• Azizah M Malebari, Ahdab N Khayyat, Ruba A Mahdali, Jumana S Alamoudi, Bushra Y Alsayed, and Samar A Alrasheed.
• Department of Pharmaceutical Chemistry, College of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. E-mail. amelibary@kau.edu.sa.
• Saudi Med J. 2020 Aug 1; 41 (8): 849857849-857.

ObjectivesTo assess community pharmacists' knowledge and practices regarding screening risk factors and providing safety information about the use of non- steroidal anti-in ammatory drugs (NSAIDs) to patients.MethodsCross-sectional and a self-administered questionnaire-based study was conducted over a 4-month period (May-August 2019) with selected community pharmacies in Jeddah, Saudi Arabia. The questionnaire composed of demographic data and the pharmacist's role in supplying NSAIDs.ResultsThe majority of participating community pharmacists dispense NSAIDs. However, many did not apply relevantly good communication skills such as seeking information about concomitant drugs (42.5%) or providing advice on managing any adverse side effects of taking NSAIDs (39.1%). Most of the community pharmacists also did not provide relevantly good communication about risk factors. The most common screening risk factors mentioned were a history of pregnancy and breastfeeding (84.2%) followed by being at an older age (74.5%) or a history of a gastrointestinal ulcer (71.5%).ConclusionCommunity pharmacists in Saudi Arabia need to appropriately screen their patients for adverse drug reactions and the ectively communicate the risks of using NSAIDs. The Saudi Regulatory Authority could endorse several approaches to apply a good strategy for improving the dispensing practices in community pharmacies, communication and awareness of risk factors especially in high-risk patients who are taking NSAIDs.

25 keywords...

hide…